If you work in biotech or pharma, the real test isn't how many security tools you've bought. It's the moment an FDA investigator asks: "Show me who accessed this system, what they did, and when."

Most teams can't answer that directly. They scramble through spreadsheets, screenshots, and scattered tickets, hoping nothing critical is missing.

This guide gives a practical, step-by-step approach to FDA inspection readiness using Iden as your identity governance layer. You'll see how to:

  • Make access controls Part 11-ready across lab, clinical, and quality systems
  • Eliminate "partial offboarding" and orphaned accounts-classic FDA findings
  • Generate FDA-ready documentation in minutes, not weeks
  • Move from one-off audit prep to continuous, real-time FDA compliance

Between 2014 and 2018, the FDA issued roughly 3,362 Form 483 observations per year, with many tied to record, report, and laboratory controls1pharmtech.com. Most audit pain points trace directly to gaps in documentation and data integrity-especially fragmented access control and missing audit trails.

Iden doesn't fix your batch records or clinical protocols. It fixes the identity and access layer beneath them-so when the FDA asks, "Who did what, when, and why?" you have a single, trustworthy answer.

What you'll get from this guide

By the end, you'll know how to:

  • Inventory all GxP-relevant systems and identities
  • Design FDA-ready access policies and enforce segregation of duties (SoD)
  • Automate provisioning, deprovisioning, and access changes
  • Build immutable, audit-ready evidence for inspections
  • Pressure-test your controls with internal mock FDA audits

This is for lean IT, Security, and QA/CSV teams in biotech and pharma-the 3-10 people tasked with FDA compliance, as headcount and "silly SaaS" apps keep growing.

Prerequisites: what you need before you start

You don't need a large IAM team. You do need minimal structure:

  • SSO + HRIS in place Okta, Microsoft Entra, or similar, plus an HR system (Workday, ADP, BambooHR, etc). This is your source of truth for people and roles.

  • List of GxP-relevant systems Examples: LIMS, ELN, MES, QMS, EDC/CTMS, DMS, ERP (SAP/Oracle), CRM (Veeva, Salesforce), and any custom tool that creates or stores GxP data.

  • Named system owners At least one person per system who understands usage in GMP/GCP/GDP contexts.

  • Baseline role definitions Start with rough roles like "QC analyst," "QA reviewer," "Manufacturing operator," "CRA," "Data manager."

  • Iden connected to core systems Connect SSO and HRIS first, pilot with key GxP systems. Iden's universal connectors handle SCIM, non-SCIM SaaS, and legacy tools-zero engineering required.

Tip If you can't name all GxP systems, start from your validation inventory, eTMF, and SOPs. Any "computerized system" in scope for GxP is fair game.

Step 1 - Clarify inspection scope and data integrity expectations

Start by aligning on what the FDA will actually focus on.

For biotech and pharma, identity and access sits at the intersection of GMP/GCP rules (21 CFR Parts 210, 211, 312, 820) and 21 CFR Part 11 requirements.

21 CFR Part 11 governs electronic records and signatures. It requires valid systems, secure, time-stamped audit trails, and technical access controls.2fda.gov

When inspectors ask about "data integrity," they really mean:

  • Is every action attributable to a real person (no shared logins)?
  • Can you show who did what, when, and why in a protected audit trail?3qt9software.com
  • Are permissions tightly aligned to job roles (least privilege)?
  • Are changes to access controlled, approved, and tracked?

Incomplete audit trails, shared accounts, missing metadata, and unvalidated spreadsheets are top root causes for FDA inspection failures.4fdaguidelines.com

Common mistake Treating "FDA audit prep" as a document chase. If you don't fix identity and access at the system level, your reports are just prettier versions of unreliable data.

Map your upcoming inspection type (pre-approval, routine, for-cause) and tie it to likely systems and processes in scope5manufacturingdive.com. That defines your audit boundary.

Step 2 - Map systems, data, and identities into one GxP inventory

Visibility first. Map who can touch which GxP records, via which identity, in which system.

  1. Catalog all regulated systems Include:

    • Lab: LIMS, ELN, chromatography/analytical
    • Manufacturing: MES, SCADA/HMI, batch control
    • Quality: QMS, deviation/CAPA, training
    • Clinical: EDC, CTMS, IxRS, eCOA
    • Business: ERP, Veeva Vault, Salesforce

  2. Aggregate all identities via Iden:

    • Employees from HRIS
    • Accounts/groups from SSO/AD
    • Local accounts from non-SSO systems (legacy/SaaS)
    • Bots, service accounts, lab equipment identities

  3. Tag GxP scope for systems and entitlements:

    • Anything creating/modifying FDA electronic records (Part 11)
    • Touching product quality, safety, or submissions

  4. Link people -> roles -> entitlements Example: "Jane is a QC analyst at Site A and has these permissions in LIMS, QMS, MES, DMS."

Tip Don't overlook "edge" access: contractor VPNs, vendor support, shared lab terminals. Inspectors catch these first.

Iden's universal connectors pull in SCIM, non-SCIM, API, or legacy tools-total coverage, no SCIM-tax upgrade required.

Step 3 - Design FDA-ready access policies and SoD controls

Visibility turns to control.

Your goal: policy-driven, least-privilege access that maps to quality processes and GxP requirements.

  1. Define roles in each GxP domain

    • QC Analyst: create/modify test results, not COA approval
    • QA Reviewer: read/approve only, no raw data edits
    • Manufacturing Operator: execute recipes, no config
    • Sysadmin: configure, not data entry

  2. Map roles to entitlements in Iden:

    • "QC Analyst"-LIMS project X, Y (edit), QMS (create deviation), no admin
    • "QA Reviewer"-LIMS (read), DMS (approve), QMS (signoff)

    Iden supports fine-grained control: channel, project, module-not just broad group membership.

  3. Enforce segregation of duties (SoD):

    • No one can create and approve the same batch record
    • No one can both configure and validate a system
    • No lone analyst can unblind and approve clinical efficacy

    Iden policies block risk combos and route exceptions for approval.

  4. Enable just-in-time (JIT) access When rare tasks arise (vendor troubleshooting, patching), grant time-bound access that expires and is fully logged.

Common mistake Mirroring your AD groups as "roles." Historic groups rarely match GxP responsibilities. Start with process, design roles intentionally.

Step 4 - Automate provisioning, modifications, and offboarding

You know what good access looks like. Automate it.

  1. Automate joiners

    • New hire in HR triggers Iden
    • Iden applies your policies, provisions rights in all key apps-zero tickets or Slack threads

  2. Automate movers

    • Role or site change updates entitlements
    • Old access removed, new granted
    • SoD rules flag risk, QA/IT approve exceptions

  3. Automate leavers

    • HR termination = full, tracked deprovisioning
    • Iden disables/removes accounts even in local, non-SCIM apps-no forgotten zombies

Iden customers cut manual access tickets by up to 80% in the first 60 days through policy-driven automation.

Common mistake Disabling in SSO ≠ full offboarding. Lab and SaaS tools often allow direct or cached logins. FDA inspectors are catching zombie accounts-easy findings.

Step 5 - Build continuous, audit-ready evidence with immutable logs

FDA wants good controls-and proof.

Part 11 requires secure, computer-generated, time-stamped audit trails capturing all operator actions-who, what, when, and preserving prior entries.6qualityze.com

With Iden:

  1. Centralize audit trails at the identity layer:

    • Access requests
    • Approvers (and policies used)
    • Provisioning/deprovisioning records
    • Changes to roles/policies

  2. Align audit data to FDA asks

    • Reports for admin rights, access histories, and periodic reviews-ready to export

  3. Schedule evidence generation

    • Monthly access reviews
    • On-demand for batches, studies, CAPAs

Automated user access reviews in Iden save around 120 hours of manual work per quarter for lean IT teams.

Tip Treat identity logs as regulated records. Validate generation, storage, and backups. Document this in your Part 11 and CSV packages.

Step 6 - Run a mock FDA audit using Iden

Now, pressure-test your stack before the FDA does.

  1. Form a lean "audit squad" QA, IT/IAM, CSV, plus a system owner.

  2. Draft 5-10 real audit requests

    • List all computerized systems with GMP data
    • For specific batches, show access history and entitlements
    • Prove user access reviews for all Part 11 systems over 12 months

  3. Answer all with Iden first

    • Inventory for systems and GxP tags
    • Pull access reports, history, logs

  4. Compare to current SOPs

    • Any systems still outside Iden?
    • Any fallback to spreadsheets?
    • Any SoD or least-privilege assumptions proven wrong?

  5. Log all gaps as CAPAs Feed findings back into Iden policies, connector roll-out, and SOP updates.

Common mistake Reducing mock audits to paperwork. If your "evidence" isn't from real, immutable logs, you're just doing compliance theater.

Step 7 - Make audit readiness continuous, not seasonal

Static checks can't keep up with continuous attacks-or your business.

Use Iden to keep FDA compliance always-on:

  • Continuous access reviews Replace annual rubber-stamp reviews with shorter, frequent checks focused on high-risk systems and roles.

  • Agentic workflows for anomalies Iden's AI-driven workflows automatically spot:

    • Orphaned accounts
    • SoD violations from org changes
    • Over-provisioned roles Then trigger remediation and evidence capture in real time.

  • Track KPIs that actually matter

    • Time from termination to complete deprovisioning
    • Orphaned/zombie accounts found per month
    • % of GxP systems with automated lifecycle governance

  • Integrate quality records Push Iden logs into QMS for deviations, CAPAs, and periodic reviews. Every identity-related control is documented and inspectable.

Next steps

If FDA inspection is coming, act quickly:

  • Week 1: Connect SSO and HRIS to Iden. Map top 5-10 GxP systems.
  • Week 2: Define roles, SoD, and joiner-mover-leaver policies in Iden.
  • Week 3: Turn on automated provisioning/offboarding for one critical system. Run your first internal mock audit.

Expand from there. Iden's connectors get you coverage even for "difficult" tools lacking SCIM/APIs, so you're not stuck with legacy gaps.

Bring a real inspection scenario to a 20-minute walkthrough and see how fast you can answer FDA's core questions through a unified view.

FAQ: FDA audits, identity governance, and Iden

How does identity governance relate to FDA inspections?

FDA inspections are about data integrity, documentation, and control of electronic systems. Part 11 mandates secure audit trails and controlled access. Identity governance proves only the right people acted and every step is traceable.

Does FDA require a specific tool like Iden for Part 11 compliance?

No. FDA mandates outcomes: validated systems, verifiable electronic records, audit trails, and strong access controls. Iden helps you meet all of these-across SCIM, non-SCIM, cloud, SaaS, and legacy systems-with evidence and speed. You still need good SOPs, validation, and governance.

Our lab/manufacturing systems aren't in SSO. Can Iden still help?

Absolutely. Most risk hides there. Iden's universal connectors integrate with systems lacking SCIM or modern APIs, bringing all identities and permissions into your lifecycle automation and audit trail.

How far ahead of an FDA inspection should we implement this?

The earlier, the better-it takes time to fix access sprawl. Still, Iden can be live in about 24 hours for core systems, with ticket reduction and audit-grade reporting within weeks.Iden deployments can reach production in about 24 hours; early customers automate key access workflows in under one hour of configuration. Even if your audit is soon, you can mitigate risk and improve evidence right away.

Do we still need CSV and traditional Part 11 validation with Iden?

Yes. Iden strengthens identity and access controls with consistent, immutable logs, but every regulated system needs its own validation, SOPs, and quality documentation. Treat Iden as a GxP-relevant tool: include it in your validation inventory and reference its audit logs in your procedures and FDA submissions.